restor3d Expands Healthcare Innovation | Welcomes New Robotics and Navigation Experts

restor3d, the medical technology leader in 3D printed, personalized orthopedic implants, announced its strategic expansion into the field of robotics and navigation through the appointment of seasoned leaders, Larry Hazbun and Kirstin Widding.

restor3d is at the forefront of innovation in the field of personalized orthopedic solutions, utilizing advanced 3D printing technology to create patient-specific implants that match the natural human anatomy and provide optimal osseointegration. The company is expanding its capabilities into the realm of robotics and navigation for the surgical delivery of patient specific implants. This expansion aligns with restor3d’s mission to improve patient care through cutting-edge implant technology and also positions the company to offer a suite of tools in the future that allow surgeons to perform patient specific implant procedures using their preferred method of enabling technology.

“We welcome the addition of Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee.” Said Ken Gall, restor3d Chief Commercial Officer and Co-Founder. “The addition of robotics and navigation technologies is a natural fit with personalization and a perfect compliment to our patient specific implants. By integrating these enabling technologies with our existing 3D-printed patient specific implants and instruments, restor3d is poised to offer a more holistic approach to personalized patient treatment.”

Larry is a forward-thinking executive with over 25 years in leadership of research and development across automotive, aerospace, and medical industries. Before joining restor3d, Larry was the VP of Product Development for the Imaging, Navigation, and Robotics business unit at Globus Medical focusing on navigated and robotic spine surgery. Prior to that, Larry held multiple leadership roles at Mako Surgical Corp, which later went on to be acquired by Stryker, and was instrumental in the development of the Mako robotic assisted surgical platform for total knee, hip, and other orthopedic applications.

Kirstin brings extensive experience as a strategic commercial leader in total hip, knee, shoulder, and enabling technologies with a proven track record of driving revenue growth through impactful integrated marketing, communications, branding, and product solutions. With an unparalleled focus on customer satisfaction, she has successfully developed commercialization strategies, strengthened corporate brands, and built strong relationships with surgeons and distributor partners. Her expertise in business development, strategic partnerships, and product portfolio management, combined with a commitment to innovation and collaboration, positions her as a key change agent within the industry.

With the strategic expansion into robotics and navigation, coupled with the leadership of Larry Hazbun and Kirstin Widding, restor3d is well-positioned to continue its trajectory of innovation in the orthopedic industry. The company remains committed to pushing the boundaries of personalized healthcare, delivering solutions that include both patient specific implants and a multitude of personalized surgical delivery systems. As restor3d continues to integrate these enabling technologies, it reaffirms its dedication to transforming the future of orthopedic surgery and enhancing patient outcomes worldwide.

Sourcerestor3d

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”